JP2009516747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009516747A5 JP2009516747A5 JP2008542425A JP2008542425A JP2009516747A5 JP 2009516747 A5 JP2009516747 A5 JP 2009516747A5 JP 2008542425 A JP2008542425 A JP 2008542425A JP 2008542425 A JP2008542425 A JP 2008542425A JP 2009516747 A5 JP2009516747 A5 JP 2009516747A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- independently
- carbocyclyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(BC(*1)(*C2(*)*)*C2(*)N[U][U]*)(C2)C12I Chemical compound *C(BC(*1)(*C2(*)*)*C2(*)N[U][U]*)(C2)C12I 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73891905P | 2005-11-22 | 2005-11-22 | |
| US60/738,919 | 2005-11-22 | ||
| PCT/US2006/045151 WO2007062093A2 (en) | 2005-11-22 | 2006-11-21 | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009516747A JP2009516747A (ja) | 2009-04-23 |
| JP2009516747A5 true JP2009516747A5 (https=) | 2010-01-14 |
| JP5256042B2 JP5256042B2 (ja) | 2013-08-07 |
Family
ID=37994504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542425A Expired - Fee Related JP5256042B2 (ja) | 2005-11-22 | 2006-11-21 | 癌の処置のための併用療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8324194B2 (https=) |
| EP (1) | EP1951242A2 (https=) |
| JP (1) | JP5256042B2 (https=) |
| CA (1) | CA2628747C (https=) |
| WO (1) | WO2007062093A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088737B2 (en) * | 2003-04-04 | 2012-01-03 | Incyte Corporation | Compositions, methods and kits relating to Her-2 cleavage |
| NZ543102A (en) * | 2003-04-24 | 2008-12-24 | Incyte Corp | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| AU2004282189B2 (en) | 2003-10-17 | 2011-11-17 | Incyte Holdings Corporation | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| WO2007016597A2 (en) * | 2005-07-29 | 2007-02-08 | The Regents Of The University Of California | Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy |
| US7910108B2 (en) | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
| DK2851374T3 (en) | 2007-12-14 | 2017-06-19 | Bristol Myers Squibb Co | Binding molecules to the human OX40 receptor |
| EP2438443A4 (en) * | 2009-06-02 | 2012-07-25 | Targeted Molecular Diagnostics Llc | METHOD FOR DETECTING AND QUANTIFYING THE P95 COMPONENT OF HER2 / NEU (ERBB2) |
| WO2011083391A2 (en) | 2010-01-05 | 2011-07-14 | Pfizer Inc. | Biomarkers for anti-igf-ir cancer therapy |
| PT2614082T (pt) | 2010-09-09 | 2018-12-03 | Pfizer | Moléculas de ligação a 4-1bb |
| GB201116092D0 (en) | 2011-09-16 | 2011-11-02 | Bioceros B V | Antibodies and uses thereof |
| JP6404717B2 (ja) * | 2012-03-02 | 2018-10-17 | ジェネンテック， インコーポレイテッド | アミドスピロ環状アミド及びスルホンアミド誘導体 |
| CN102600073B (zh) * | 2012-03-31 | 2014-01-01 | 莱普德制药有限公司 | 以乳酸酯为基础的氟维司群或其衍生物油性制剂及其制备方法 |
| AU2013255511B2 (en) | 2012-05-04 | 2016-01-28 | Pfizer Inc. | Prostate-associated antigens and vaccine-based immunotherapy regimens |
| SMT201800503T1 (it) | 2013-03-18 | 2018-11-09 | Janssen Pharmaceuticals Inc | Anticorpi anti-cd (ox40) umanizzati e loro usi |
| CA2909418A1 (en) * | 2013-04-18 | 2014-10-23 | Xi'an Libang Pharmaceutical Technology Co., Ltd. | Ester derivative of 7-.alpha.-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)n onyl]-estra-1,3,5(10)-triene-3,17.beta.-diol having anticancer activity and preparation method thereof |
| CN111511762B (zh) | 2017-08-21 | 2025-05-06 | 天演药业公司 | 抗cd137分子及其用途 |
| WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| WO2019148444A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Anti-ctla4 antibodies and methods of making and using the same |
| TW202200622A (zh) | 2020-05-13 | 2022-01-01 | 瑞士商天演藥業公司 | 用於治療癌症之組成物及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008172D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Therapy |
| CN1729002A (zh) * | 2000-09-08 | 2006-02-01 | 法玛西雅意大利公司 | 依西美坦作为化学预防剂 |
| JP2004519490A (ja) | 2001-01-26 | 2004-07-02 | フアルマシア・イタリア・エツセ・ピー・アー | エキセメスタンによるホルモン依存性異常症の組合せ治療方法 |
| US8088737B2 (en) * | 2003-04-04 | 2012-01-03 | Incyte Corporation | Compositions, methods and kits relating to Her-2 cleavage |
| NZ543102A (en) * | 2003-04-24 | 2008-12-24 | Incyte Corp | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| AU2004282189B2 (en) * | 2003-10-17 | 2011-11-17 | Incyte Holdings Corporation | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| WO2005117882A2 (en) * | 2004-04-20 | 2005-12-15 | Incyte Corporation | Hydroxamic acid derivatives as metalloprotease inhibitors |
| US7910108B2 (en) | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
-
2006
- 2006-11-21 WO PCT/US2006/045151 patent/WO2007062093A2/en not_active Ceased
- 2006-11-21 CA CA2628747A patent/CA2628747C/en active Active
- 2006-11-21 US US11/602,659 patent/US8324194B2/en active Active
- 2006-11-21 EP EP06838238A patent/EP1951242A2/en not_active Withdrawn
- 2006-11-21 JP JP2008542425A patent/JP5256042B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009516747A5 (https=) | ||
| CA2628747A1 (en) | Combinations of hormone therapy agents and metalloprotease inhibitors for the treatment of cancer | |
| US6291505B1 (en) | Estrogen receptor modulators | |
| US7186838B2 (en) | Fluorinated 4-azasteroid derivatives as androgen receptor modulators | |
| CN101243052B (zh) | 螺旋结构12定位的非甾族抗雄激素物质 | |
| JP5595402B2 (ja) | アンドロゲン受容体モジュレーターとしての新規イミダゾリジン化合物 | |
| US10730856B2 (en) | Benzimidazole derivatives as EP4 ligands | |
| JP2022521824A (ja) | アンドロゲン受容体の阻害剤を含む薬学的組成物及びその組み合わせならびにその使用 | |
| US20100331333A1 (en) | Imidazo [1,2-B] Pyridazine Compounds | |
| US10344034B2 (en) | Pyrazolopyrimidone or Pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereof | |
| CN101175747A (zh) | 作为选择性雄激素受体调节剂的取代的n-芳基吡咯烷化合物 | |
| WO2004041277A1 (en) | Carbonylamino-benzimidazole derivatives as androgen receptor modulators | |
| JP4607860B2 (ja) | 腫瘍阻害作用を有する抗−アンドロゲン性ピロリジン | |
| JP2002522425A (ja) | エストロゲンレセプターモジュレーターとしての置換イソオキサゾール | |
| CN105873917A (zh) | 含有吡啶基部分的非甾体类抗雄激素和选择性雄激素受体调节剂 | |
| MX2011002899A (es) | Compuestos de amida utiles en terapia. | |
| KR20150036319A (ko) | 3-치환된 에스트라-1,3,5(10),16-테트라엔 유도체, 그의 제조방법, 이를 포함하는 약학 제제 및 의약품 제조를 위한 그의 용도 | |
| US20100324073A1 (en) | Pyrazolo [1,5-A] Pyrimidine Compounds | |
| Nakagawa et al. | Progesterone receptor antagonists with a 3-phenylquinazoline-2, 4-dione/2-phenylisoquinoline-1, 3-dione skeleton | |
| ES2264032T3 (es) | Derivados de n-fenilamino-1h-imidazol como inhibidores de la aromatasa. | |
| US6737433B1 (en) | 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them | |
| HK1223609B (zh) | 含有吡啶基部分的非甾体类抗雄激素和选择性雄激素受体调节剂 | |
| JP2007204371A (ja) | 複素環誘導体 | |
| JP2002543154A (ja) | ２，１−ベンゾイソチアゾリン２，２−ジオキシドおよびプロゲステロン剤を含む避妊薬組成物 | |
| OA12973A (en) | 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors. |